Session

Sessions

Nanoscope Therapeutics: Optogenetic Therapies For Retinal Degenerative Disease – Clinical Developments And Updates

Sessions

Annexon Biosciences: Protection of Vision and Structure in GA

Sessions

Astellas: All Eyes on Geographic Atrophy

Sessions

Bayer: Up for debate: points of view in retinal care

Sessions

Bayer: A Turning Point in DME

Sessions

Bayer: A Turning Point in nAMD

Sessions

Lumibird Medical: Controversies on modern laser treatments for retina and vitreous

Sessions

Alcon: Alcon Eye to Eye: Innovation, Precision & Integration

Sessions

EURETINA IME Platform on Digital Visualization: New Technologies Bring Key Improvements to the Real World

Sessions

EURETINA IME Platform on Dry AMD & GA: Implementing Modern Diagnosis and Management Approaches in Today’s Practice

Sessions

Bayer: What is Bayer’s vision for the future of ophthalmology?

Sessions

Bayer: Is sustained disease control the new benchmark for patient care?

Sessions

Bayer: Have we maximised patient outcomes, or can we go further?

Sessions

Lumibird: Laser for retina and vitreous: All you need to know in 2023

Sessions

IME: Dry AMD & GA IME Platform: Practical Considerations for GA Treatment